Market Tracker

03/29 4:50am ET

Cambrex Corp (NYSE:CBM)

51.40
Delayed Data
As of Mar 28
 +0.80 / +1.58%
Today’s Change
38.30
Today|||52-Week Range
62.50
-4.73%
Year-to-Date

Today’s Trading

Previous close50.60
Today’s open50.40
Day’s range50.20 - 51.55
Volume237,778
Average volume (3 months)327,152
Market cap$1.7B
Dividend yield--
Data as of 03/28/2017

Growth & Valuation

Earnings growth (last year)+40.91%
Earnings growth (this year)+4.76%
Earnings growth (next 5 years)+12.00%
Revenue growth (last year)+13.23%
P/E ratio19.4
Price/Sales3.63
Price/Book4.04

Competitors

 Today’s
change
Today’s
% change
GBTGlobal Blood Therape...-0.70-1.77%
SRPTSarepta Therapeutics...-0.76-2.49%
PCRXPacira Pharmaceutica...-0.15-0.32%
ARRYArray Biopharma Inc-0.09-0.96%
Data as of 03/28/2017

Financials

Next reporting dateMay 5, 2017
EPS forecast (this quarter)$0.48
Annual revenue (last year)$490.6M
Annual profit (last year)$81.7M
Net profit margin17.80%

Profile

Sector
Process Industries
Industry
Chemicals: Specialty
President, Chief Executive Officer &
Director
Steven M. Klosk
Chief Operating Officer &
Executive Vice President
Shawn P. Cavanagh
Corporate headquarters
East Rutherford, New Jersey

Forecasts